The COVID-19 vaccine being developed by British-Swedish pharmaceutical giant AstraZeneca with the University of Oxford could be key to curbing the pandemic in many low- and middle-income countries ...

An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on ...

An experimental coronavirus vaccine developed by Oxford University and drug manufacturer AstraZeneca appears to be up to 90% effective, the two partners announced Monday. The encouraging results co… ...

AstraZeneca and the University of Oxford announced Monday that late-stage trials show their COVID-19 vaccine was up to 90% effective in preventing the disease.

The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday. CNN values your feedback 1.

Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient ...

Oxford University and AstraZeneca announced its trial results on Monday but has since suffered a barrage of criticism over how they had collated and presented the interim results for the third and ...

This month, the Oxford vaccine became the first to have its Phase 3 clinical trial results published in a peer-reviewed medical journal, the Lancet, which confirmed the initial findings that the ...

The World Health Organization approved the AstraZeneca/Oxford Covid-19 vaccine for emergency use Monday, which could help developing countries access the vaccine and make it easier for other ...

The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday. CNN values your feedback 1.